HC Wainwright & Co. Reiterates Buy on Gritstone Bio, Maintains $4 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Sean Lee has reiterated a Buy rating on Gritstone Bio (NASDAQ:GRTS) and maintained a $4 price target.
August 15, 2024 | 11:42 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Sean Lee has reiterated a Buy rating on Gritstone Bio and maintained a $4 price target.
The reiteration of a Buy rating and the maintenance of a $4 price target by a reputable analyst can positively influence investor sentiment and potentially drive short-term price appreciation for Gritstone Bio.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100